UnknownNCT02127463
Phase II/III Study of the Efficacy and Safety of MacuCLEAR MC-1101 in Treating DryAge-Related Macular Degeneration
PHASE2 · PHASE3 · 60 planned enrolment
- Countries listed
- 1
- Registry update
- April 30, 2014
immortal.lifeVerify the exact trial registrations behind a company, intervention, programme or topic count.
Showing 1–2 of 2. Every record below meets all the filters shown above.
PHASE2 · PHASE3 · 60 planned enrolment
PHASE2 · PHASE3 · 22 planned enrolment